Experimental hypersensitivity pneumonitis: Role of MCP-1

Journal of Laboratory and Clinical Medicine

Volumn 142, Issue 3, 2003, Pages 187-195

  Schuyler, Mark ^a,b   Gott, Katherine ^a   Cherne, Amy ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CYTOKINE ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC PNEUMONITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; IN VITRO STUDY; INFECTIOUS PNEUMONIA; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SACCHAROPOLYSPORA; SENSITIZATION; SPLEEN CELL; WILD TYPE;

EID: 0141990923     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(03)00107-0     Document Type: Article

References (61)

1. Schuyler M. Hypersensitivity pneumonitis. In: Fishman A, ed. Pulmonary diseases and disorders. 3rd ed. McGraw-Hill, NY, 1997:1085-97.
2. Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Hoogsteden HC, van den Bosch JM. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Resp J 1993;6:1276-81.
3. Denis M. Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Resp Crit Care Med 1995;151:164-9.
4. Sugiyama Y, Kasahara T, Mukaida N, Matsushima K, Kitamura S. Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. Eur Resp J 1995;8:1084-90.
5. Schuyler M. Gott K, Cherne A. Mediators of hypersensitivity pneumonitis. J Lab Clin Med 2000;136:29-38.
6. Kurihara T, Bravo R. Cloning and functional expression of mCCR2, a murine receptor for the C- C chemokines JE and FIC. J Biol Chem 1996;271:11603-7.
7. Boring L, Gosling J, Monteclaro FS, Lusis AJ, Tsou CL, Charo IF. Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9. J Biol Chem 1996;271:7551-8.
8. Yamagami S, Tokuda Y, Ishii K, Tanaka H, Endo N. cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor. Biochem Biophys Res Commun 1994;202:1156-62.
9. Schuyler M, Gott K, Cherne A, Edwards B. Th1 CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Cell Immunol 1997;177:169-75.
10. Schuyler M. Gott K, Haley P. Experimental murine hypersensitivity pneumonitis. Cell Immunol 1991;136:303-17.
11. Schuyler M, Gott K, Shopp G, Crooks L. CD3+ and CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Am Rev Resp Dis 1992;146:1582-8.
12. Campbell EM, Charo IF, Kunkel SL, Strieter RM, Boring L, Gosling J, et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J Immunol 1999;163:2160-7.
13. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol 1999;163:6148-54.
14. Fillion I, Quellet N, Simard M, Bergeron Y, Sato S, Bergeron MG. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. J Immunol 2001;166:7353-61.
15. Schuyler M, Gott K, Edwards B, Nikula KJ. Experimental hypersensitivity pneumonitis. Effect of CD4 cell depletion. Am J Resp Crit Care Med 1994;149:1286-94.
16. Schuyler M. Hypersensitivity pneumonitis. In: Fishman A, ed. Pulmonary diseases and disorders. 3rd ed. McGraw-Hill, NY, 1997:1085-97.
17. Systat for Windows, version 8.0: Statistics. Evanston, IL: SPSS Inc; 1998.
18. Dawson TC, Beck MA, Kuziel WA. Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000;156:1951-9.
19. Moore BB, Paine R 3rd. Christensen PJ, Moore TA, Sitterding S, Ngan R, et al. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 2001;167:4368-77.
20. Blease K, Mehrad B, Standiford TJ, et al. Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice. J Immunol 2000;165:2603-11.
21. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 2000;164: 2021-7.
22. Schuyler M, Gott K, Mapel V, Cherne A, Nikula KJ. Experimental hypersensitivity pneumonitis: influence of Th2 bias. Int J Exp Pathol 1999:80:335-48.
23. Kunkel SL, Strieter RM, Lindley IJ, Westwick J. Chemokines: new ligands, receptors and activities. Immunol Today 1995;16: 559-61.
24. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999;103:773-8.
25. Villiger PM, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992;149:722-7.
26. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 1996;156:3017-23.
27. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 1992;89:5371-5.
28. Rosseau S, Hammerl P, Maus U, Walmrath HD, Schutte H, Grimminger F, et al. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000;279:L25-35.
29. Gillitzer R, Wolff K, Tong D, Muller C, Yoshimura T, Hartmann AA, et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 1993;101:127-31.
30. Fujinaka H, Yamamoto T, Takeya M, Feng L, Kawasaki K, Yaoita E, et al. Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats. J Am Soc Nephrol 1997; 8:1174-8.
31. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, et al. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol 1997;159:401-8.
32. Russell ME, Adams DH, Wyner LR, Yamashita Y, Halnon NJ, Karnovsky MJ. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci U S A 1993;90:6086-90.
33. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990;136:1229-33.
34. Paine R 3rd, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, Strieter RM. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol 1993;150:4561-70.
35. Brieland JK, Flory CM, Jones ML, Miller GR, Remick DG, Warren JS, et al. Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. Am J Respir Cell Mol Biol 1995;12: 104-9.
36. Poon M, Hsu WC, Bogadanov VY, Taubman MB. Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am J Pathol 1996;149:307-17.
37. Hogaboam CM, Bone-Larson CL, Lipinski S, Lukacs NW, Chensue SW, Strieter RM, et al. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J Immunol 1999;163:2193-201.
38. Frade JM, Mellado M, del Real G, Gutierrez-Ramos JC, Lind P, Martinez AC. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol 1997;159:5576-84.
39. Sarafi MN, Garcia-Zepeda EA, MacLean JA, Charo IF. Luster AD. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 1997;185:99-109.
40. Albini A, Ferrini S, Benelli R, Storzini S, Ginncinglio D. Aluigi MG, et al. HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A 1998;95:13153-8.
41. Garcia-Zepeda EA, Combadiere C, Rothenberg ME, et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157:5613-26.
42. Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem 1997;272: 11682-5.
43. Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao JL, Murphy PM. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 1995;270:29671-5.
44. Brieland JK, Jones ML, Clarke SJ, Baker JB, Warren JS, Fantone JC. Effect of acute inflammatory lung injury on the expression of monocyte chemoattractant protein-1 (MCP-1) in rat pulmonary alveolar macrophages. Am J Resp Cell Mol Biol 1992;7:134-9.
45. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 1994;153: 4733-41.
46. Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Keefer C, Strieter RM. et al. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 1997;150: 1861-8.
47. Schuyler M, Gott K, Shopp G, Crooks L. CD3+ , CD4+, CD8-, Ia- T cells adoptively transfer murine experimental hypersensitivity pneumonitis. Chest 1993;103:143S-145S.
48. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 1997;186:39-45.
49. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 1997;94:12053-8.
50. Boring L. Gosling J, Chensue SW, Kunkel S L, Farese RV, Jr, Broxmeyer HI, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-61.
51. Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997;186:1757-62.
52. Sato N, Ahuja SK, Quinones M, Kosteiki V, Reddick RL, Melby PC, et al. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 2000;192:205-18.
53. Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001;167:4585-92.
54. Izikson L, Klein RS, Charo IE, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000; 192:1075-80.
55. Magram J, Sfarra J, Connaughton S, Faherty D, Warrier R, Carvajal D, et al. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann N Y Acad Sci 1996; 795:60-70.
56. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997;7:571-81.
57. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998;187:601-8.
58. Smith SM, Burrell R, Snyder IS. Complement activation by cell wall fractions of Micropolyspora faeni. Infect Immun 1978;22: 568-74.
59. Denis M, Cormier Y, Tardif J, Ghadirian E, Laviolette M. Hypersensitivity pneumonitis: whole Micropolyspora faeni or antigens thereof stimulate the release of proinflammatory cytokines from macrophages. Am J Resp Cell Mol Biol 1991;5:198-203.
60. Bice D, McKarron K, Huffman E, Salvaggio J. Adjuvant properties of Micropolyspora faeni. Int Arch Allergy Appl Immunol 1974;55:267-73.
61. Matsukawa A, Lukacs NW, Standiford TJ, Chensue SW, Kunkel SL. Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo. J Immunol 2000;164:1699-704.